Gimbal Financial acquired a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 1,002 shares of the medical research company’s stock, valued at approximately $289,000. Several other large investors also recently bought and sold shares of the […]
Amgen (NASDAQ:AMGN – Free Report) had its target price cut by TD Cowen from $370.00 to $360.00 in a research report released on Wednesday morning, Benzinga reports. They currently have a buy rating on the medical research company’s stock. A number of other brokerages also recently weighed in on AMGN. Daiwa Capital Markets upgraded Amgen […]
WP Advisors LLC lowered its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,454 shares of the medical research company’s stock after selling 187 shares during the period. WP Advisors LLC’s […]
Commerzbank Aktiengesellschaft FI boosted its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,759 shares of the medical research company’s stock after acquiring an additional 407 […]
Commerzbank Aktiengesellschaft FI raised its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 43,759 shares of the medical research company’s stock after buying an additional 407 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Amgen were worth $12,603,000 at the end […]